Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from RedHill Biopharma ( (RDHL) ).
On January 22, 2026, RedHill Biopharma filed a Form 6-K announcing an Extraordinary General Meeting of Shareholders to be held on March 5, 2026, in Tel Aviv. The meeting will ask shareholders to approve grants of restricted share units tied to ADSs for non-executive directors, CEO and chairman Dror Ben-Asher, and Chief Commercial Officer and director Rick D. Scruggs, as well as an increase in the company’s authorized share capital. Only holders of record of ADSs at the close of business on January 23, 2026, will be entitled to vote, with the board recommending support for all proposals, signaling an effort to align management and director incentives with shareholders while expanding the company’s capacity to issue additional equity in the future.
The most recent analyst rating on (RDHL) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on RedHill Biopharma stock, see the RDHL Stock Forecast page.
Spark’s Take on RDHL Stock
According to Spark, TipRanks’ AI Analyst, RDHL is a Neutral.
Score is held down primarily by weak financial performance (ongoing losses, negative equity, and negative operating/free cash flow). Technicals provide a partial offset with improving short-term trend and momentum, but longer-term trend and MACD remain unsupportive. Valuation impact is neutral due to missing P/E and dividend yield.
To see Spark’s full report on RDHL stock, click here.
More about RedHill Biopharma
RedHill Biopharma Ltd. is an Israel-based biopharmaceutical company, listed in the United States as a foreign private issuer, that operates through American Depositary Shares (ADSs) representing its ordinary shares. The company is governed under Israeli corporate law and maintains its shareholder relations and capital market activities in coordination with the U.S. Securities and Exchange Commission, reflecting a focus on international capital markets and ADR investors.
Average Trading Volume: 979,956
Technical Sentiment Signal: Sell
Current Market Cap: $6.67M
Learn more about RDHL stock on TipRanks’ Stock Analysis page.